Paul Gregor
Amministratore Delegato presso Rimonyx Pharmaceuticals Ltd.
Profilo
Paul Gregor is the founder and the Chief Executive Officer of Romonyx Pharmaceuticals Ltd., which was founded in 2001.
He also held former positions as a Technology Director at W World Corp., a Principal at The Salk Institute for Biological Studies, Bayer Pharmaceuticals Corp., National Institutes of Health, and National Institute on Drug Abuse.
Dr. Gregor's education includes an undergraduate degree from Weizmann Institute of Science.
Posizioni attive di Paul Gregor
| Società | Posizione | Inizio |
|---|---|---|
Rimonyx Pharmaceuticals Ltd.
 Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Amministratore Delegato | 01/01/2002 |
Precedenti posizioni note di Paul Gregor
| Società | Posizione | Fine |
|---|---|---|
| W WORL | Direttore Tecnico/Scientifico/R&S | - |
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| The Salk Institute for Biological Studies | Corporate Officer/Principal | - |
| National Institute on Drug Abuse | Corporate Officer/Principal | - |
Formazione di Paul Gregor
| Weizmann Institute of Science | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| W WORL | Health Technology |
| Aziende private | 4 |
|---|---|
Rimonyx Pharmaceuticals Ltd.
Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Health Technology |
| National Institute on Drug Abuse | Government |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
| Bayer Pharmaceuticals Corp. |
- Borsa valori
- Insiders
- Paul Gregor
